EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer’s Disease in Down Syndrome

Jessica A Beresford-Webb, Catherine J McAllister, Alison Sleigh, Madeleine J Walpert, Anthony J Holland, Shahid H Zaman

Brain Sciences · 28.01.2025 · 15 (2) · 130

DOI: 10.3390/brainsci15020130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 28.01.2025. Verfasst von Jessica A Beresford-Webb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Trumpington R…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Alzheimer's Research UK, The Baily Thomas Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Mitochondrial dysfunction is increasingly recognized as a central contributor to neurodegenerative diseases and age-related cognitive decline. Individuals with Down syndrome (DS) are at high risk of neurodegeneration due to Alzheimer’s disease (AD). This study aims to explore the relationship between mitochondrial dysfunction, brain amyloid-beta (Aβ) deposition, and cognitive decline in this population.

Methods

We investigated mitochondrial function, brain amyloid-beta burden, and cognitive performance in a pilot study of a cohort of 10 eligible adults with DS selected from a sample of 28 individuals with DS. Phosphorus-31 magnetic resonance spectroscopy (31P-MRS) was used to assess mitochondrial function in skeletal muscle using a post-exercise paradigm, while positron emission tomography using 11C-Pittsburgh compound B (PiB-PET) measured brain Aβ deposition. Cognitive performance was evaluated using the Cambridge Cognitive Examination adapted for individuals with Down syndrome (CAMCOG-DS) and executive function batteries.

Results

Significant correlations were observed between slowed phosphocreatine (PCr) recovery in muscle and increased Aβ deposition in key brain regions, particularly the striatum. Cognitive performance inversely correlated with mitochondrial function, with pronounced deficits in memory and executive function tasks. Notably, an individual carrying the APOE-ε4 allele exhibited the poorest mitochondrial function, highest Aβ burden, and most severe cognitive impairment, suggesting a potential interaction between genetic risk and mitochondrial health.

Conclusions

These findings highlight the role of mitochondrial dysfunction in DS-associated AD (DSAD) and its impact on cognition in adults. The results support targeting mitochondrial pathways as a potential therapeutic strategy to mitigate AD progression in DS populations. Further research with larger cohorts and longitudinal designs is needed to clarify causative mechanisms and develop effective interventions.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseDown syndromedementiamitochondria

Autor:innen und Institutionen

  • Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Trumpington Road, Cambridge CB2 8AH, UK.
  • Wolfson Brain Imaging Centre, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Institute of Metabolic Science, Cambridge Biomedical Campus, Camb…
  • Cambridgeshire & Peterborough Foundation NHS Trust, Douglas House, Trumpington Road, Cambridge CB2 8AH, UK.

Förderung

  • Medical Research Council
  • Alzheimer's Research UK
  • The Baily Thomas Charitable Trust
  • Addenbrooke's Charitable Trust
  • Alzheimer’s Research UK
  • Addenbrooke’s Charitable Trust
  • Health Foundation
  • National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care

Zitieren

APA

Beresford-Webb, J. A., McAllister, C. J., Sleigh, A., Walpert, M. J., Holland, A. J., & Zaman, S. H. (2025). Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer’s Disease in Down Syndrome. Brain Sciences, 15(2), 130. https://doi.org/10.3390/brainsci15020130

Vancouver

Beresford-Webb JA, McAllister CJ, Sleigh A, Walpert MJ, Holland AJ, Zaman SH. Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer’s Disease in Down Syndrome. Brain Sciences. 2025;15(2):130. doi:10.3390/brainsci15020130

BibTeX
@article{BeresfordWebb2025,
  author = {Beresford-Webb, Jessica A and McAllister, Catherine J and Sleigh, Alison and Walpert, Madeleine J and Holland, Anthony J and Zaman, Shahid H},
  title = {Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer’s Disease in Down Syndrome},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {130},
  doi = {10.3390/brainsci15020130}
}
Kostenlos starten →